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Interventional Cardiology
Dual Drug Resistance to Aspirin and Clopidogrel
The etiology of aspirin resistance is not known and is likely multifactorial. If it iscaused by a defect in a final common pathway of platelet activation, patientsmay
also be resistant to clopidogrel. Lev and colleagues assayed several differentmeasures of
platelet activity in response to clopidogrel in patients taking aspirin.Using their criteria,
13%were resistant to aspirin and 24% to clopidogrel; more importantly, half of those
resistant to aspirin were also resistant to clopidogrel. Both aspirin and clopidogrel
resistant patients were about twice as likely to have creatine kinase-MB elevations after
elective percutaneous coronary intervention than sensitive patients; those resistant to
both were three times as likely. Aspirin and clopidogrel resistance are both common; a
high percentage of patients may be resistant to both medications and at much greater
risk for adverse cardiovascular outcomes. See page 27. See figure.
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Myocardial Infarction
MRI Quantifies Infarct Healing After Primary Angioplasty
The time frame for and extent of myocardial recovery after apparently successfultreatment for acute myocardial infarction (MI) has not previously been studied
with magnetic resonance imaging (MRI). Baks and colleagues performed MRIs on
patientswhopresentedwithST-segment elevationMIandwere successfully reperfused
with emergent angioplasty within 6 h of symptom onset. The MRIs were performed
five days after presentation and then repeated five months later. They quantified
microvascular perfusion,wall thickness, and infarct size (area of delayed enhancement).
Infarct size shrank by about one-third over the five months. In segments with normal
microvascular perfusion, the wall thickness was increased at five days, suggesting either
edemaor hyperemia, andwallmotion recovered after fivemonths. Segmentswith poor
microvascular perfusion at five days demonstrated wall thinning at fivemonths and no
recovery in wall motion. This study and this technique will be useful in evaluating new
therapies that seek to improve functional recovery after acuteMI.See page 40. See
figure.
Metabolic Syndrome
Metabolic Syndrome Leads to Accelerated Arterial Stiffness
Arterial stiffness can be assayed by measuring the systolic blood pressure, the pulsepressure, or the pulse wave velocity (PWV) of blood flow in the central arteries.
Stiff arteries have less elasticity and thus more of the force of ejection is converted into
blood movement and less to arterial expansion. In this study, Safar and colleagues
measured PWV in subjects with a range of cardiovascular risk factors at baseline and
then six years later. Patients with no cardiovascular risk factors had no change in PWV,
but subjects with three ormore risk factors (patients with themetabolic syndrome) had
clear evidence of arterial stiffening over this time frame. This study confirms that the
metabolic syndrome is a diffuse process that leads to widespread maladaptive changes
in the arterial tree. See page 72.
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Heart Failure
BNP Levels Lower in Obese Patients With Heart Failure
Recent reports have suggested that B-type natriuretic peptide (BNP) levels may berelatively lower inobese thannon-obese subjects.This has important implications
asBNPhasbecomewidelyusedboth to assay for thepresenceor absenceof heart failure
and its severity. Horwich and colleagues compared BNP levels in over 300 patients
with systolic heart failure (left ventricular ejection fraction40%) stratified by body
mass index . They report two significant findings. Firstly, for unknown reasons, BNP
levels are lower in obese patients compared to non-obese patients with similar hemo-
dynamics. The second important finding is that even in obese patients, elevated BNP
remains a significant predictor of adverse outcomes, but different cut-off values should
be used. See page 85. See figure.
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Cardiac Imaging
Comparing Imaging Modalities to Identify Wall Motion Abnormalities
Identifying regional wall motion abnormalities (RWMA) has important prognosticimplications, but most methods rely on qualitative interpretations rather than
quantitative assessments. This study by Hoffmann and colleagues sought to compare
interobserver and intermethod accuracy of RWMA determinations using cineventric-
ulography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced
echocardiography. They found only moderate interobserver agreement (IOA) for all
methods. Contrast was found to substantially improve IOA for echocardiography;
contrast echocardiography had the best correlation with clinical history. Magnetic
resonance imagingwas found tobe subject toover- orunder-readingwithpoor IOAfor
RWMA despite clear endocardial borders. Defining RWMA requires both interpret-
able images and experience correlating images with anatomy; quantitative methods
may be required in the future to improve IOA. See page 121. See figure.
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Cardiac Ultrasound
Myocardial Contrast Echocardiography Similar to SPECT for CAD Detection
Visualizing myocardial perfusion with real time ultrasound has been technicallychallenging.New ultrasound contrast agents and standardized protocols are now
increasing its feasibility. Jeetley and colleagues compared the sensitivity and specificity
of myocardial contrast echocardiography (MCE) with single-photon emission com-
puted tomography (SPECT) for the detection of coronary artery disease (CAD) in
patients with intermediate to high likelihood of CAD. Coronary angiography was
performed as the gold standard. Subjects received dipyridamole as a vasodilator; they
were then injected with sestamibi (to be imaged 60 min later) and infused with
myocardial contrast bubbles which were immediately imaged with apical windows.
Perfusion was assessed by destroying the myocardial bubbles and qualitatively timing
the re-appearance ofmyocardial bubbles.Theoverall sensitivity forMCEwas84%and
for SPECT was 82% with similar specificity. Myocardial contrast echocardiography
maynowbe as reliable as SPECT for assessing cardiovascular perfusion and subsequent
risk. See page 141. See figure.
